3 completed, 1 active not recruiting, 1 recruiting. 3 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 3 |
| Phase 2 | 2 | Active not recruiting 1, Recruiting 1 |
Follow HRS-5965 Capsules: new trials by email Literature Review of HRS-5965 Capsules trials Research Report on HRS-5965 Capsules
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Trial to Evaluate the Long-term Safety and Tolerability of HRS-5965 in Patients With Primary IgA Nephropathy HRS-5965 Capsules - Primary IgA Nephropathy | Phase 2 | Recruiting | Chengdu Suncadia Medicine Co., Ltd. | 380 | 2026-07-06 | 2026-07-22 |
| Investigation of Drug-drug Interaction of HRS-5965 With Clopidogrel and Clarithromycin in Healthy Subjects HRS-5965 Capsules, Clopidogrel, Clarithromycin - Complement Mediated Glomerular Diseases, Hemolytic Anemia | Phase 1 | Completed | Chengdu Suncadia Medicine Co., Ltd. | 36 | 2025-07-08 | 2025-08-20 |
| A Clinical Study to Evaluate the Effect of Food on the Pharmacokinetic Profiles of HRS-5965 Capsules in Healthy Subjects HRS-5965 Capsules - IgA Nephropathy, Paroxysmal Nocturnal Hemoglobinuria | Phase 1 | Completed | Chengdu Suncadia Medicine Co., Ltd. | 16 | 2025-06-30 | 2025-08-20 |
| Investigation of Pharmacokinetics,Safety,and Pharmacodynamics of HRS-5965 in Subjects With Hepatic Impairment HRS-5965 capsules - Complement Mediated Primary or Secondary Glomerular Diseases | Phase 1 | Completed | Chengdu Suncadia Medicine Co., Ltd. | 24 | 2024-11-26 | 2026-01-30 |
| Long-term Safety and Tolerability of HRS-5965 in Patients With Paroxysmal Nocturnal Hemoglobinuria HRS-5965 tablets, HRS-5965 Capsules - Paroxysmal Nocturnal Hemoglobinuria | Phase 2 | Active not recruiting | Chengdu Suncadia Medicine Co., Ltd. | 132 | 2024-02-06 | 2025-12-24 |
Glomerulonephritis, IGA (2) · Hemoglobinuria, Paroxysmal (2) · Anemia, Hemolytic (1)
Chengdu Suncadia Medicine Co., Ltd. (5)
China (5)